BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 15635025)

  • 41. Differences in the evolution of imipenem susceptibility among Klebsiella pneumoniae and Escherichia coli isolates during a 6-year period in a tertiary care hospital.
    Papaparaskevas J; Pantazatou A; Stefanou I; Mela V; Galatidis N; Avlamis A
    Int J Antimicrob Agents; 2007 Feb; 29(2):197-200. PubMed ID: 17207610
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Susceptibility patterns of clinical and fish isolates of Laribacter hongkongensis: comparison of the Etest, disc diffusion and broth microdilution methods.
    Lau SK; Wong GK; Poon RW; Lee LC; Leung KW; Tse CW; Ho PL; Que TL; Woo PC; Yuen KY
    J Antimicrob Chemother; 2009 Apr; 63(4):704-8. PubMed ID: 19202149
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Indirect Tris-EDTA Disk Testing Using Imipenem and Meropenem for Detection of OXA-48 Carbapenemase Production.
    Thomson GK; AbdelGhani S; Snyder JW; Thomson KS
    J Clin Microbiol; 2015 Nov; 53(11):3705-6. PubMed ID: 26292309
    [No Abstract]   [Full Text] [Related]  

  • 44. Characterization of TEM-, SHV- and AmpC-type beta-lactamases from cephalosporin-resistant Enterobacteriaceae isolated from swine.
    Rayamajhi N; Kang SG; Lee DY; Kang ML; Lee SI; Park KY; Lee HS; Yoo HS
    Int J Food Microbiol; 2008 May; 124(2):183-7. PubMed ID: 18455821
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection of synergy using the combination of polymyxin B with either meropenem or rifampin against carbapenemase-producing Klebsiella pneumoniae.
    Pankey GA; Ashcraft DS
    Diagn Microbiol Infect Dis; 2011 Aug; 70(4):561-4. PubMed ID: 21767715
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro activities of three carbapenems against recent bacterial isolates from severely ill patients at Swedish hospitals.
    Fraenkel CJ; Ullberg M; Bernander S; Ericson E; Larsson P; Rydberg J; Törnqvist E; Melhus A
    Scand J Infect Dis; 2006; 38(10):853-9. PubMed ID: 17008228
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of porin loss on the activity of tigecycline against Klebsiella pneumoniae producing extended-spectrum beta-lactamases or plasmid-mediated AmpC-type beta-lactamases.
    Conejo MC; Hernández JR; Pascual A
    Diagn Microbiol Infect Dis; 2008 Jul; 61(3):343-5. PubMed ID: 18339509
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro activity of tigecycline against clinical isolates of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae, Serratia marcescens and Enterobacter cloacae.
    Ku YH; Chuang YC; Yu WL
    J Microbiol Immunol Infect; 2008 Aug; 41(4):332-6. PubMed ID: 18787741
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Imipenem-susceptible, meropenem-resistant Klebsiella pneumoniae producing OXA-181 in Japan.
    Kayama S; Koba Y; Shigemoto N; Kuwahara R; Kakuhama T; Kimura K; Hisatsune J; Onodera M; Yokozaki M; Ohge H; Sugai M
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1379-80. PubMed ID: 25512424
    [No Abstract]   [Full Text] [Related]  

  • 50. Convenient test using a combination of chelating agents for detection of metallo-beta-lactamases in the clinical laboratory.
    Kim SY; Hong SG; Moland ES; Thomson KS
    J Clin Microbiol; 2007 Sep; 45(9):2798-801. PubMed ID: 17596358
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece.
    Pournaras S; Protonotariou E; Voulgari E; Kristo I; Dimitroulia E; Vitti D; Tsalidou M; Maniatis AN; Tsakris A; Sofianou D
    J Antimicrob Chemother; 2009 Aug; 64(2):348-52. PubMed ID: 19525514
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Porin loss and GES-type extended-spectrum beta-lactamase primarily responsible for reduced susceptibility to imipenem.
    Lee SH; Lee JH; Bae SJ; Bae IK; Jeong SH
    Diagn Microbiol Infect Dis; 2007 Jun; 58(2):261-2. PubMed ID: 17300909
    [No Abstract]   [Full Text] [Related]  

  • 53. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
    Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M
    Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of imipenem and meropenem on serum sensitivity and surface hydrophobicity of Klebsiella pneumoniae.
    Hostacká A
    Arzneimittelforschung; 1998 Nov; 48(11):1101-3. PubMed ID: 9850433
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Klebsiellapneumoniae isolates possessing KPC beta-lactamase in Israel, Puerto Rico, Colombia and Greece.
    Hawser SP; Bouchillon SK; Hoban DJ; Hackel M; Johnson JL; Badal RE
    Int J Antimicrob Agents; 2009 Oct; 34(4):384-5. PubMed ID: 19560904
    [No Abstract]   [Full Text] [Related]  

  • 56. Comparison of carbapenem minimum inhibitory concentrations of Oxacillin-48-like Klebsiella pneumoniae by Sensititre, Vitek 2, MicroScan, and Etest.
    Nana T; Perovic O; Chibabhai V
    Clin Microbiol Infect; 2022 Dec; 28(12):1650.e1-1650.e5. PubMed ID: 35811020
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Results of two worldwide surveys into physician awareness and perceptions of extended-spectrum beta-lactamases.
    Goossens H; Malhotra-Kumar S; Eraksoy H; Unal S; Grabein B; Masterton R; Mendes C; Garcia-Rodriguez JA; Russo G; Jones RN;
    Clin Microbiol Infect; 2004 Aug; 10(8):760-2. PubMed ID: 15301682
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of imipenem/imipenem+EDTA disk method for detection of metallo-beta-lactamase-producing Klebsiella pneumoniae isolated from blood cultures.
    Petropoulou D; Tzanetou K; Syriopoulou VP; Daikos GL; Ganteris G; Malamou-Lada E
    Microb Drug Resist; 2006; 12(1):39-43. PubMed ID: 16584307
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae.
    Anderson KF; Lonsway DR; Rasheed JK; Biddle J; Jensen B; McDougal LK; Carey RB; Thompson A; Stocker S; Limbago B; Patel JB
    J Clin Microbiol; 2007 Aug; 45(8):2723-5. PubMed ID: 17581941
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In Vitro Comparison of Ertapenem, Meropenem, and Imipenem against Isolates of Rapidly Growing Mycobacteria and Nocardia by Use of Broth Microdilution and Etest.
    Brown-Elliott BA; Killingley J; Vasireddy S; Bridge L; Wallace RJ
    J Clin Microbiol; 2016 Jun; 54(6):1586-1592. PubMed ID: 27053677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.